focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 226.50
Bid: 226.00
Ask: 227.00
Change: 0.50 (0.22%)
Spread: 1.00 (0.442%)
Open: 225.00
High: 229.50
Low: 224.00
Prev. Close: 226.00
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: PureTech Health's Akili secures USD160 million in financing

Wed, 26th May 2021 18:03

PureTech Health PLC - clinical-stage biotherapeutics company - Notes investee Akili Interactive has secured USD160 million of combined equity and debt financing. Says funding will accelerate commercialization of Akili's flagship treatment EndeavorRx, enable expansion of Akili's core technology to treat acute and chronic cognitive disorders, and drive further research and development of new technologies to treat broader range of conditions.

Current stock price: 378.50p

Year-to-date change: down 5.4%

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
7 Jul 2020 16:35

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

Read more
23 Jun 2020 07:29

PureTech's Akili gets CE-mark for 'EndeavourRx'

(Sharecast News) - Biotherapeutics company PureTech Health said its founded entity Akili had received a CE-mark for 'EndeavorRx treatment for attention deficit hyperactivity disorder (ADHD).

Read more
18 Jun 2020 18:49

IN BRIEF: Puretech Health Partners With China Medical System

IN BRIEF: Puretech Health Partners With China Medical System

Read more
16 Jun 2020 14:34

IN BRIEF: PureTech's Akili In Green Light For Video Game ADHD Therapy

IN BRIEF: PureTech's Akili In Green Light For Video Game ADHD Therapy

Read more
16 Jun 2020 07:29

PureTech gets FDA clearance for video game ADHD treatment

(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health announced on Tuesday that its subsidiary Akili has been granted US Food and Drug Administration (FDA) clearance for 'EndeavorRx', or AKL-T01, as a prescription treatment for children with attention deficit hyperactivity disorder (ADHD).

Read more
9 Jun 2020 13:25

UK TRADING UPDATE SUMMARY: Venture Life Sees Order Boost For Sanitiser

UK TRADING UPDATE SUMMARY: Venture Life Sees Order Boost For Sanitiser

Read more
9 Jun 2020 08:40

PureTech Health sees 'positive' topline data from Phase 1 on IBD candidate

(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health reported some "positive" topline data from two Phase 1 studies into VE202, its orally-administered inflammatory bowel disease treatment candidate.

Read more
4 Jun 2020 13:19

UK TRADING UPDATE SUMMARY: Open Orphan Launches Covid Testing Service

UK TRADING UPDATE SUMMARY: Open Orphan Launches Covid Testing Service

Read more
2 Jun 2020 12:57

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

Read more
2 Jun 2020 07:37

PureTech firm Gelesis gets Europe approval for 'Plenity'

(Sharecast News) - Clinical stage biotherapeutics company PureTech Health announced on Tuesday that its founded company Gelesis has received approval to market 'Plenity', a novel weight-loss treatment, in Europe.

Read more
28 May 2020 14:49

UK TRADING UPDATE SUMMARY: PureTech, N4, Synairgen Advance Covid Work

UK TRADING UPDATE SUMMARY: PureTech, N4, Synairgen Advance Covid Work

Read more
28 May 2020 07:57

PureTech to advance LYT-100 as potential Covid treatment

(Sharecast News) - PureTech Health announced plans on Thursday to advance its wholly-owned clinical-stage product candidate 'LYT-100', or deupirfenidone, as a potential treatment for serious respiratory complications, including inflammation and fibrosis, that persist following the resolution of Covid-19 infection.

Read more
26 May 2020 14:22

UK EXECUTIVE CHANGE SUMMARY: New Chairs For Matomy And Shield

UK EXECUTIVE CHANGE SUMMARY: New Chairs For Matomy And Shield

Read more
26 May 2020 08:51

PureTech Health lowers stake in founded entity

(Sharecast News) - Clinical stage biotechnology company PureTech Health said on Tuesday that it had received $45m from the sale of 555,500 shares of its founded entity Karuna Therapeutics.

Read more
18 May 2020 13:46

UK DIRECTOR DEALINGS SUMMARY: Novacyt Chair And CEO Step In To Buy

UK DIRECTOR DEALINGS SUMMARY: Novacyt Chair And CEO Step In To Buy

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.